Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
145
datasets available to search
ShareScore release 0.9.0
Dataset results
145 results for “T-cell receptor”
T-cell receptor repertoire analysis of advanced solid tumors in first-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody [TCR-seq]
GEO Series GSE120101. Homo sapiens. 105 samples. Type: Expression profiling by high throughput sequencing.
Potential Role of HTLV-1 Tax-Specific Cytotoxic T Lymphocytes expressing a Unique T-cell Receptor to Promote Inflammation of the Central Nervous System in Myelopathy Associated with HTLV-1
GEO Series GSE210786. Homo sapiens. 3 samples. Type: Expression profiling by high throughput sequencing.
Data from: High-throughput sequencing of the T-cell receptor beta chain gene distinguishes two subgroups of cutaneous T-cell lymphoma
[No abstract entered]
Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma
ClinicalTrials.gov study NCT04205838. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
ClinicalTrials.gov study NCT06253520. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies
ClinicalTrials.gov study NCT07135466. IPD Sharing: YES. Countries: 1. Publications: 0.
3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA
ClinicalTrials.gov study NCT02439788. IPD Sharing: Not stated. Countries: 1. Publications: 0.
B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma
ClinicalTrials.gov study NCT07193628. IPD Sharing: NO. Countries: 1. Publications: 0.
GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02)
ClinicalTrials.gov study NCT06789081. IPD Sharing: NO. Countries: 0. Publications: 0.
CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol
ClinicalTrials.gov study NCT05648019. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases
ClinicalTrials.gov study NCT06939166. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous Nephropathy
ClinicalTrials.gov study NCT07266181. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT05680922. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT03938987. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cu
ClinicalTrials.gov study NCT07055477. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory B-cell Ma
ClinicalTrials.gov study NCT05836896. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.
ClinicalTrials.gov study NCT06786299. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia
ClinicalTrials.gov study NCT05043571. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT05326243. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
ClinicalTrials.gov study NCT06083883. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.